A dysfunctional STAT1 variant, which is unable to translocate into the nucleus upon cytokine stimulation and fails to inhibit STAT3, can trigger lymphomagenesis, as STAT3 becomes more active and contributes to lymphoid malignancy and tumor progression. This evidence concerns the gene STAT3 and neoplasm.